IP Verse

Boehringer Ingelheim competitive analysis

Latest oppositions filed by Boehringer Ingelheim

Explore patent oppositions filed by Boehringer Ingelheim against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition Date
EP3546580
Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M.Hyopneumoniae Strains, And Use ThereofHIPRA SCIENTIFICJun 3, 2026
EP4298150
New Phosphonated Non-Fluorinated And Partially Fluorinated Aryl Polymers From Sulfonated Aryl Polymers And New Polymeric Perfluorophosphonic Acids From Perfluorosulfonic Acids, Their Process Of Preparation And Use In Electromembrane ApplicationsRIVA POWER SYSTEMSSep 18, 2025
EP3842456
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 13, 2025
EP3653645
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESMay 20, 2025
EP4107159
5-(3-(Ethylsulfonyl)Pyridin-2-Yl)-Pyrazolo[1,5-A]Pyrimidine Derivatives And Related Compounds As Pesticide And Insecticide Agents For Crop ProtectionPI INDUSTRIESJan 16, 2025
EP3300743
Methods Of Vaccine AdministrationZOETIS SERVICESMar 13, 2024
EP3733672
Heterocyclic Compounds And Noxious Arthropod Control Agent Containing SameSUMITOMO CHEMICALDec 20, 2023
EP3471766
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Infectious Bursal Disease Virus AntigensINTERVETSep 12, 2023
EP3165600
Cell Culture Medium Comprising Small PeptidesLIFEAug 1, 2023
EP3874047
Carbon-Source Regulated Protein Production In A Recombinant Host CellLONZAJan 9, 2023

Latest patents of Boehringer Ingelheim opposed by its competitors

Explore Boehringer Ingelheim's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3868400
May 13, 2026Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions1
EP3766518
Jan 28, 2026Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs1
EP3700529
Jul 9, 2025New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)2
EP4426307
Jul 2, 2025New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung Diseases2
EP3826642
Jun 11, 2025Empagliflozin For Use In Treating Alport Syndrome1
EP2152341
Apr 2, 2025Atomizer, And Filter2
EP3453403
Jan 22, 2025Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation1
EP3539540
Dec 18, 2024Pharmaceutical Composition, Methods For Treating And Uses Thereof11
EP2488145
Apr 24, 2024Containers For Compositions Comprising Meloxicam1
EP3150200
Apr 10, 2024Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses Thereof4

Latest PTAB cases involving Boehringer Ingelheim

Discover the latest PTAB cases involving Boehringer Ingelheim, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 17, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Boehringer Ingelheim

PGR2022-00037May 2, 2022SANDOZBOEHRINGER INGELHEIMInstitution Denied
PGR2022-00021Dec 22, 2021BOEHRINGER INGELHEIM ANIMAL HEALTH USAKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInstitution Denied
PGR2022-00021Dec 22, 2021HRINGKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInstitution Denied
PGR2020-00076Jul 22, 2020BOEHRINGER INGELHEIM ANIMAL HEALTH USAKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONFinal Written Decision
PGR2020-00076Jul 22, 2020HRINGKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONFinal Written Decision
IPR2019-00374Nov 30, 2018INTERVETBOEHRINGER INGELHEIMInstitution Denied
IPR2019-00374Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICAInstitution Denied
IPR2019-00381Nov 30, 2018INTERVETBOEHRINGER INGELHEIMTerminated-Settled
IPR2019-00381Nov 30, 2018INTERVETBOEHRINGER INGELHEIM VETMEDICATerminated-Settled
IPR2018-01788Sep 24, 2018INTERVETBOEHRINGER INGELHEIMInstitution Denied

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HRING17322 -
CEVA SANTE ANIMALE235 - -
INTERVET124341
LABORATORIOS HIPRA9 - - -